Cognition, Metacognition, and Stigma in Patients With Suicidal Ideation
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-60
SponsorUniversity of Pittsburgh
About this trial
Deficits of executive function, meta cognition and stigma is known in suicidal ideation; however, their relationship is unknown. Since many studies use a single indicator of executive function and, it was considered important to study. Metacognition, executive functioning and stigma are the possible driving force behind the suicidal behavior in human being. With respect to research in the Indian context, there is paucity of studies exploring these factors. The purpose of the present study is to explore the relationships between executive functioning, metacognition, and stigma in suicidal ideation and suicide attempters in the Indian setup, where there is a lacuna in research regarding the same. Having a detailed understanding of these psychological parameters will be helpful in suicide prevention and management.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Any gender
Age between 18 to 60 years.
Able to read and write in Hindi and English
With a primary mental health diagnosis of anxiety, depression, acute stress reaction or adjustment disorder, or with no diagnosis at all
Disqualifiers
Any comorbid personality disorder diagnosis
Diagnosis of a major mental disorder such as Schizophrenia or Bipolar Affective Disorder.
Intellectual Disability and neurological disorder.
Trial population
The present study is a cross sectional study. For the purpose of this study, individuals with suicidal ideation and attempts who are seeking treatment at the outpatient department of Psychiatry, as well as medical emergency of Dr. RML Hospital or referred to Department of Clinical Psychology would be approached to participate in the study.
Trial design
Design model
Case-only
Time perspective
Cross-sectional
Treatments tested in this trial
Suicide ideation or suicide attempt
BehavioralIndividuals with high suicide ideation or suicide attempts visiting ABVIMS -Dr. RML Hospital for treatment will be screened for this study. socio- demographics details will also be gathered. Following this Depression, Anxiety and Stress Scale (DASS-21), Wisconsin Card Sorting Test (WCST), Metacognitions Scale (MCQ-30) and Stigma of Suicide Scale (SOSS) will be administered.
Treatment groups
212 Participants
are divided into 1 treatment groupGroup A: Persons with suicide attempt or suicide ideation1 intervention
Trial outcomes
Primary outcomes
1
Metacognition measured by Metacognitions Questionnaire (MCQ-3) scores
The Metacognitions Questionnaire-30 (MCQ-30) is a self-report measure that assesses metacognitive beliefs. The MCQ-30 is comprised of five factors. Responses are required on a four-point scale ranging from 1 (do not agree) to 4 (agree very much), high scores reflect more reported problems with the item in question.
Time frame
Within one week2
Depression, Anxiety and Stress Scale-21 scores
Depression, Anxiety and Stress Scale-21 Items (DASS-21): The Depression, Anxiety and Stress Scale - 21 Items (DASS-21) is a set of three self-report scales designed to measure the emotional states of depression, anxiety and stress. The anxiety scale assesses autonomic arousal, skeletal muscle effects, situational anxiety, and subjective experience of anxious affect. The stress scale is sensitive to levels of chronic nonspecific arousal. It assesses difficulty relaxing, nervous arousal, and being easily upset / agitated, irritable / over-reactive and impatient. Scores for depression, anxiety and stress are calculated by summing the scores for the relevant items.Higher scores mean more anxiety or depression and low scores means low anxiety or depression.
Time frame
Within one week3
Stigma of Suicide Scale (SOSS) scores
The Stigma of Suicide Scale is designed to assess stigmatizing attitudes of general community members toward people who suicide. The short form consists of 16 items. Each item consists of a one-word descriptor of a person who dies by suicide. We will use the short form. Each item is to be rated on a 5-point Likert scale from (1) strongly disagree to (5) strongly agree. Higher scores indicate higher levels of stigma towards people who suicide.
Time frame
Within one weekLocations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
University of Pittsburgh
Lead sponsor
Fogarty International Center of the National Institute of Health
Collaborator
Source ClinicalTrials.gov
This trial is not recruiting at the moment. You can still explore other options: